Neurological Archives - The James Lind Library The James Lind Library

HEALTH PROBLEMS — NEUROLOGICAL

SORT date ▼ author clear filters

26 RECORDS
4 ARTICLES

FILTER RECORDS BY

Wartolowska KA, Collins GS, Hopewell S, Judge A, Dean BJF, Rombach I, Beard DJ, Carr AJ (2016)
Feasibility of surgical randomised controlled trials with a placebo arm: a systematic review. BMJ Open 6: p.e010194.

View

Misemer BS, Platts-Mills TF, Jones CW (2016)
Citation bias favoring positive clinical trials of thrombolytics for acute ischemic stroke: a cross-sectional analysis. Trials 17:473.

View

Scott S, Kranz JE, Cole J, Lincecum JM, Thompson K, Kelly N, Bostrom A, Theodoss J, Al-Nakhala BM, Vieira FG, Ramasubbu J, Heywood JA (2008)
Design, power, and interpretation of studies in the standard murine model of ALS. Amyotrophic Lateral Sclerosis 9:4-15. DOI: 10.1080/17482960701856300.

View

Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S (2001)
Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. New England Journal of Medicine 344:710–719.

View

Bickel H, Gerrard J, Hickmans EM. (1953)
Influence of phenylalanine intake on phenylketonuria. Lancet 265:812-813.

View

Hammon W, Coriell LL, Stokes J (1952)
Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis: 1. Plan of controlled field tests and results of 1951 pilot study in Utah. JAMA 150:739-749.

View

Appelbaum E, Nelson J, Albin MB (1949)
The treatment of penumococcic meningitis with penicillin; a study of 125 consecutive cases, with 73% recovery. American Journal of Medicial Science 218:260-4.

View

Kottke FJ, Teigen BS, Siegel S, Knapp ME (1948)
Evaluation of aids to muscle reeducation in the treatment of poliomyelitis. Archives of Physical Medicine and Rehabilitation 30:141-147.

View

Medical Research Council (1948)
Streptomycin treatment of tuberculous meningitis. Lancet 1:582-596.

View

Bahlke AM, Perkins JE (1945)
Gamma globulin in poliomyelitis. JAMA 129:1146-1150.

View

Gregory KK, West EJ, Stevens RE (1940)
Epidemic cerebrospinal meningitis (meningococcic): the treatment of 113 patients with antimeningococcus serum, meningococcus antitoxin and sulfanilamide. JAMA 115:1091-5.

View

Jordan JH, Blakelock, Johnston WR (1940)
Treatment of cerebrospinal fever with suphapyridine. BMJ 1:1005-1008.

View

Banks HS (1939)
Chemotherapy of meningococcal meningitis. Lancet 2:921-927.

View

Goodhart R, Jolliffe N (1938)
Effects of vitamin B (B1) therapy on the polyneuritis of alcohol addicts. JAMA 110:414-419.

View

Gilliam AG, Onstott RH (1936)
Results of field studies with poliomyelitis vaccine. American Journal of Public Health 26:113-118.

View

Jolliffe N, Colbert CN (1936)
The etiology of polyneuritis in the alcohol addict. JAMA 107:642-7.

View

Walker MB (1934)
Treatment of myasthenia gravis with physostigmine. Lancet 1:1200-1201.

View

Fischer A (1934)
Human Convalescent Serum in the Treatment of Preparalytic Poliomyelitis. Am J Dis Child 48: 481-501.

View

Macnamara J (1933)
Serum therapy in poliomyelitis. BMJ 1:526-8.

View

Riding D, Corkhill NL (1932)
Prophylactic vaccination in epidemic meningococcal meningitis. Journal of Hygiene 32:258-267.

View

Falconer W (1807)
A practical dissertation on the effects of the medicinal effects of the Bath waters. London and Bath: Robinson & Crutwell. 3rd edition Bath: Meyler and London: Robinson, pp 29, 40-41, 50-52, 72-74, 99, 101, 106, 115-116, 117, 124.

View

Rollo J (1801)
A short account of the Royal Artillery Hospital at Woolwich. London: Mawman.

View

Black W (1788)
A comparative view of the mortality of the human species at all ages. London: Dilly, pp 35-38.

View

Sims J (1774)
A discourse on the best methods of prosecuting medical enquiries. London: J Johnson, p78-9, 80, 86-88, 99-101.

View

Charleton R (1770)
An inquiry into the efficacy of warm bathing in palsies. Oxford: Clarendon.

View

al-Razi (10th century CE; 4th century AH)
Kitab al-Hawi fi al-tibb [The comprehensive book of medicine].

View

Show

Yu X, Chen Y, Podolsky S (2025).
The History of Controlled Clinical Trials in China. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Kirakosian R, Möllenbrink L, Zamore G, Kaptchuk TJ, Jensen K (2023).
Heresy, witchcraft, Jean Gerson, scepticism, and the use of placebo controls. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Ritskes-Hoitinga M, Pound P (2022).
The role of systematic reviews in identifying the limitations of preclinical animal research, 2000 – 2022. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Lee MR (2004).
The miracle of St. Alfege’s: discovering a treatment for myaesthenia gravis. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

James Lind LibraryIllustrating the development of fair tests of treatments through history

HEALTH PROBLEMS — NEUROLOGICAL

SORT date ▼ author clear filters

26 RECORDS

4 ARTICLES

Wartolowska KA, Collins GS, Hopewell S, Judge A, Dean BJF, Rombach I, Beard DJ, Carr AJ (2016) Feasibility of surgical randomised controlled trials with a placebo arm: a systematic review. BMJ Open 6: p.e010194.

Misemer BS, Platts-Mills TF, Jones CW (2016) Citation bias favoring positive clinical trials of thrombolytics for acute ischemic stroke: a cross-sectional analysis. Trials 17:473.

Scott S, Kranz JE, Cole J, Lincecum JM, Thompson K, Kelly N, Bostrom A, Theodoss J, Al-Nakhala BM, Vieira FG, Ramasubbu J, Heywood JA (2008) Design, power, and interpretation of studies in the standard murine model of ALS. Amyotrophic Lateral Sclerosis 9:4-15. DOI: 10.1080/17482960701856300.

Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S (2001) Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. New England Journal of Medicine 344:710–719.

Bickel H, Gerrard J, Hickmans EM. (1953) Influence of phenylalanine intake on phenylketonuria. Lancet 265:812-813.

Hammon W, Coriell LL, Stokes J (1952) Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis: 1. Plan of controlled field tests and results of 1951 pilot study in Utah. JAMA 150:739-749.

Appelbaum E, Nelson J, Albin MB (1949) The treatment of penumococcic meningitis with penicillin; a study of 125 consecutive cases, with 73% recovery. American Journal of Medicial Science 218:260-4.

Kottke FJ, Teigen BS, Siegel S, Knapp ME (1948) Evaluation of aids to muscle reeducation in the treatment of poliomyelitis. Archives of Physical Medicine and Rehabilitation 30:141-147.

Medical Research Council (1948) Streptomycin treatment of tuberculous meningitis. Lancet 1:582-596.

Bahlke AM, Perkins JE (1945) Gamma globulin in poliomyelitis. JAMA 129:1146-1150.

Gregory KK, West EJ, Stevens RE (1940) Epidemic cerebrospinal meningitis (meningococcic): the treatment of 113 patients with antimeningococcus serum, meningococcus antitoxin and sulfanilamide. JAMA 115:1091-5.

Jordan JH, Blakelock, Johnston WR (1940) Treatment of cerebrospinal fever with suphapyridine. BMJ 1:1005-1008.

Banks HS (1939) Chemotherapy of meningococcal meningitis. Lancet 2:921-927.

Goodhart R, Jolliffe N (1938) Effects of vitamin B (B1) therapy on the polyneuritis of alcohol addicts. JAMA 110:414-419.

Gilliam AG, Onstott RH (1936) Results of field studies with poliomyelitis vaccine. American Journal of Public Health 26:113-118.

Jolliffe N, Colbert CN (1936) The etiology of polyneuritis in the alcohol addict. JAMA 107:642-7.

Walker MB (1934) Treatment of myasthenia gravis with physostigmine. Lancet 1:1200-1201.

Fischer A (1934) Human Convalescent Serum in the Treatment of Preparalytic Poliomyelitis. Am J Dis Child 48: 481-501.

Macnamara J (1933) Serum therapy in poliomyelitis. BMJ 1:526-8.

Riding D, Corkhill NL (1932) Prophylactic vaccination in epidemic meningococcal meningitis. Journal of Hygiene 32:258-267.

Falconer W (1807) A practical dissertation on the effects of the medicinal effects of the Bath waters. London and Bath: Robinson & Crutwell. 3rd edition Bath: Meyler and London: Robinson, pp 29, 40-41, 50-52, 72-74, 99, 101, 106, 115-116, 117, 124.

Rollo J (1801) A short account of the Royal Artillery Hospital at Woolwich. London: Mawman.

Black W (1788) A comparative view of the mortality of the human species at all ages. London: Dilly, pp 35-38.

Sims J (1774) A discourse on the best methods of prosecuting medical enquiries. London: J Johnson, p78-9, 80, 86-88, 99-101.

Charleton R (1770) An inquiry into the efficacy of warm bathing in palsies. Oxford: Clarendon.

al-Razi (10th century CE; 4th century AH) Kitab al-Hawi fi al-tibb [The comprehensive book of medicine].

Show ALL ARTICLES Brief histories Commentaries Biographies Personal reflections Doctoral theses

Yu X, Chen Y, Podolsky S (2025).The History of Controlled Clinical Trials in China. JLL Bulletin: Commentaries on the history of treatment evaluation.

Kirakosian R, Möllenbrink L, Zamore G, Kaptchuk TJ, Jensen K (2023).Heresy, witchcraft, Jean Gerson, scepticism, and the use of placebo controls. JLL Bulletin: Commentaries on the history of treatment evaluation.

Ritskes-Hoitinga M, Pound P (2022).The role of systematic reviews in identifying the limitations of preclinical animal research, 2000 – 2022. JLL Bulletin: Commentaries on the history of treatment evaluation.

Lee MR (2004).The miracle of St. Alfege’s: discovering a treatment for myaesthenia gravis. JLL Bulletin: Commentaries on the history of treatment evaluation.

HEALTH PROBLEMS

BROWSE

ABOUT

COPYRIGHT

FEEDBACK

James Lind Library
Illustrating the development of fair tests of treatments through history

Wartolowska KA, Collins GS, Hopewell S, Judge A, Dean BJF, Rombach I, Beard DJ, Carr AJ (2016)
Feasibility of surgical randomised controlled trials with a placebo arm: a systematic review. BMJ Open 6: p.e010194.

Misemer BS, Platts-Mills TF, Jones CW (2016)
Citation bias favoring positive clinical trials of thrombolytics for acute ischemic stroke: a cross-sectional analysis. Trials 17:473.

Scott S, Kranz JE, Cole J, Lincecum JM, Thompson K, Kelly N, Bostrom A, Theodoss J, Al-Nakhala BM, Vieira FG, Ramasubbu J, Heywood JA (2008)
Design, power, and interpretation of studies in the standard murine model of ALS. Amyotrophic Lateral Sclerosis 9:4-15. DOI: 10.1080/17482960701856300.

Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S (2001)
Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. New England Journal of Medicine 344:710–719.

Bickel H, Gerrard J, Hickmans EM. (1953)
Influence of phenylalanine intake on phenylketonuria. Lancet 265:812-813.

Hammon W, Coriell LL, Stokes J (1952)
Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis: 1. Plan of controlled field tests and results of 1951 pilot study in Utah. JAMA 150:739-749.

Appelbaum E, Nelson J, Albin MB (1949)
The treatment of penumococcic meningitis with penicillin; a study of 125 consecutive cases, with 73% recovery. American Journal of Medicial Science 218:260-4.

Kottke FJ, Teigen BS, Siegel S, Knapp ME (1948)
Evaluation of aids to muscle reeducation in the treatment of poliomyelitis. Archives of Physical Medicine and Rehabilitation 30:141-147.

Medical Research Council (1948)
Streptomycin treatment of tuberculous meningitis. Lancet 1:582-596.

Bahlke AM, Perkins JE (1945)
Gamma globulin in poliomyelitis. JAMA 129:1146-1150.

Gregory KK, West EJ, Stevens RE (1940)
Epidemic cerebrospinal meningitis (meningococcic): the treatment of 113 patients with antimeningococcus serum, meningococcus antitoxin and sulfanilamide. JAMA 115:1091-5.

Jordan JH, Blakelock, Johnston WR (1940)
Treatment of cerebrospinal fever with suphapyridine. BMJ 1:1005-1008.

Banks HS (1939)
Chemotherapy of meningococcal meningitis. Lancet 2:921-927.

Goodhart R, Jolliffe N (1938)
Effects of vitamin B (B1) therapy on the polyneuritis of alcohol addicts. JAMA 110:414-419.

Gilliam AG, Onstott RH (1936)
Results of field studies with poliomyelitis vaccine. American Journal of Public Health 26:113-118.

Jolliffe N, Colbert CN (1936)
The etiology of polyneuritis in the alcohol addict. JAMA 107:642-7.

Walker MB (1934)
Treatment of myasthenia gravis with physostigmine. Lancet 1:1200-1201.

Fischer A (1934)
Human Convalescent Serum in the Treatment of Preparalytic Poliomyelitis. Am J Dis Child 48: 481-501.

Macnamara J (1933)
Serum therapy in poliomyelitis. BMJ 1:526-8.

Riding D, Corkhill NL (1932)
Prophylactic vaccination in epidemic meningococcal meningitis. Journal of Hygiene 32:258-267.

Falconer W (1807)
A practical dissertation on the effects of the medicinal effects of the Bath waters. London and Bath: Robinson & Crutwell. 3rd edition Bath: Meyler and London: Robinson, pp 29, 40-41, 50-52, 72-74, 99, 101, 106, 115-116, 117, 124.

Rollo J (1801)
A short account of the Royal Artillery Hospital at Woolwich. London: Mawman.

Black W (1788)
A comparative view of the mortality of the human species at all ages. London: Dilly, pp 35-38.

Sims J (1774)
A discourse on the best methods of prosecuting medical enquiries. London: J Johnson, p78-9, 80, 86-88, 99-101.

Charleton R (1770)
An inquiry into the efficacy of warm bathing in palsies. Oxford: Clarendon.

al-Razi (10th century CE; 4th century AH)
Kitab al-Hawi fi al-tibb [The comprehensive book of medicine].

Show

Yu X, Chen Y, Podolsky S (2025).
The History of Controlled Clinical Trials in China. JLL Bulletin: Commentaries on the history of treatment evaluation.

Kirakosian R, Möllenbrink L, Zamore G, Kaptchuk TJ, Jensen K (2023).
Heresy, witchcraft, Jean Gerson, scepticism, and the use of placebo controls. JLL Bulletin: Commentaries on the history of treatment evaluation.

Ritskes-Hoitinga M, Pound P (2022).
The role of systematic reviews in identifying the limitations of preclinical animal research, 2000 – 2022. JLL Bulletin: Commentaries on the history of treatment evaluation.

Lee MR (2004).
The miracle of St. Alfege’s: discovering a treatment for myaesthenia gravis. JLL Bulletin: Commentaries on the history of treatment evaluation.